mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Positive opinions based on significant survival benefit
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
It will undertake academic and collaborative research activities in Ayurveda, including herbal medicine and yoga, as well as design academic standards, short-term/medium-term courses, and educational guidelines
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Subscribe To Our Newsletter & Stay Updated
